Effects of borneol on the intestinal transport and absorption of two P-glycoprotein substrates in rats

Archives of Pharmacal Research

Volumn 34, Issue 7, 2011, Pages 1161-1170

  He, Huijuan ^a   Shen, Qi ^a   Li, Jian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Bioavailability; Borneol; Colchicine; Intestinal absorption; P glycoprotein; Rhodamine123

Indexed keywords

BORNEOL; COLCHICINE; GLYCOPROTEIN P; RHODAMINE 123; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL TRANSPORT; BORNANES; COLCHICINE; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT DYES; GOUT SUPPRESSANTS; INTESTINAL ABSORPTION; INTESTINES; MALE; P-GLYCOPROTEINS; RATS; RATS, WISTAR; RHODAMINE 123;

EID: 80052326695     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0714-y     Document Type: Article

References (34)

1. T. Bansal G. Mishra M. Jaggi R. K. Khar S. Talegaonkar 2009 Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats Eur. J. Pharm. Sci. 36 580 590 19135530 10.1016/j.ejps.2008.12.005 1:CAS:528:DC%2BD1MXhs1aqurk%3D
2. J. Brouwers M. E. Brewster P. Augustijns 2009 Supersaturating drug delivery systems: the answer to solubilitylimited oral bioavailability? J. Pharm. Sci. 98 2549 2572 19373886 10.1002/jps.21650 1:CAS:528: DC%2BD1MXns1eqt7s%3D
3. Z. Cai S. Hou Y. Li B. Zhao Z. Yang S. Xu J. Pu 2008 Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration J. Drug Target 16 178 184 18274938 10.1080/10611860701794395 1:CAS:528: DC%2BD1cXhvVenu7s%3D (Pubitemid 351266554)
4. Chen, Y. M. and Wang, N. S., Effects of borneol on Pglycoprotein. Traditional Chinese Drug Research & Clinical Pharmacology, 96-99 (2003).
5. Y. M. Chen N. S. Wang 2004 Effect of borneol on the intercellular tight junction and pinocytosis vesicles in vitro blood-brain barrier model Zhongguo Zhong Xi Yi Jie He Za Zhi 24 632 634 15307705
6. P. P. Constantinides K. M. Wasan 2007 Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies J. Pharm. Sci. 96 235 248 17051593 10.1002/jps.20780 1:CAS:528:DC%2BD2sXhsFGmt7c%3D (Pubitemid 46363554)
7. A. Crowe M. Lemaire 1998 In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin Pharm. Res. 15 1666 1672 9833985 10.1023/A:1011940108365 1:CAS:528:DyaK1cXnsFSnsr8%3D (Pubitemid 28524574)
8. J. P. Dai J. Chen Y. F. Bei B. X. Han S. Wang 2009 Influence of borneol on primary mice oral fibroblasts: a penetration enhancer may be used in oral submucous fibrosis J. Oral. Pathol. Med. 38 276 281 19267840 10.1111/j.1600-0714.2008.00738.x 1:CAS:528:DC%2BD1MXkt12nsrs%3D
9. Y. Emi D. Tsunashima K. Ogawara K. Higaki T. Kimura 1998 Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine J. Pharm. Sci. 87 295 299 9523981 10.1021/js970294v 1:CAS:528:DyaK1cXovFOitg%3D%3D (Pubitemid 28204581)
10. S. J. Fisher P. W. Swaan N. D. Eddington 2010 The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo J. Pharmacol. Exp. Ther. 332 326 333 19820208 10.1124/jpet.109.158642 1:CAS:528:DC%2BC3cXis12isw%3D%3D
11. C. I. Ghanem P. C. Gómez M. C. Arana M. Perassolo G. Delli Carpini M. G. Luquita L. M. Veggi V. A. Catania L. A. Bengochea A. D. Mottino 2006 Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin J. Pharmacol. Exp. Ther. 318 1146 1152 16740618 10.1124/jpet.106.105668 1:CAS:528:DC%2BD28XovFygtr8%3D (Pubitemid 44268320)
12. P. Hsiao L. Sasongko J. M. Link D. A. Mankoff M. Muzi A. C. Collier J. D. Unadkat 2006 Verapamil Pglycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data J. Pharmacol. Exp. Ther. 317 704 710 16415090 10.1124/jpet.105.097931 1:CAS:528:DC%2BD28XktFamurg%3D
13. S. Hurst C. M. Loi J. Brodfuehrer A. El-Kattan 2007 Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans Expert Opin. Drug Metab. Toxicol. 3 469 489 17696800 10.1517/17425255.3.4.469 1:CAS:528:DC%2BD2sXptVWjtLk%3D (Pubitemid 351324958)
14. F. Hyafil C. Vergely P. Du Vignaud T. Grand-Perret 1993 In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative Cancer Res. 53 4595 4602 8402633 1:CAS:528:DyaK2cXitlWnsA%3D%3D (Pubitemid 23304385)
15. E. Molden H. Christensen R. B. Sund 2000 Extensive metabolism of diltiazem and P-glycoprotein-mediated efflux of desacetyl-diltiazem (M1) by rat jejunum in vitro Drug Metab. Dispos. 28 107 109 10640504 1:CAS:528: DC%2BD3cXot1WjtQ%3D%3D (Pubitemid 30068990)
16. E. Niel J. M. Scherrmann 2006 Colchicine today Joint Bone Spine 73 672 678 17067838 10.1016/j.jbspin.2006.03.006 1:CAS:528:DC%2BD2sXhsFahu70%3D (Pubitemid 44932240)
17. A. Oka M. Oda H. Saitoh A. Nakayama M. Takada B. J. Aungst 2002 Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells Biol. Pharm. Bull. 25 393 396 11913542 10.1248/bpb.25.393 1:CAS:528:DC%2BD38XkslWltLs%3D (Pubitemid 39663298)
18. K. Sagara I. Yamada Y. Matsuura M. Kawata M. Shibata 1996 Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules Biol. Pharm. Bull. 19 1184 1188 8889038 1:CAS:528:DyaK28XlvFCnsLo%3D (Pubitemid 26342261)
19. C. S. Schasteen M. G. Donovan J. N. Cogburn 1992 A novel in vitro screen to discover agents which increase the absorption of molecules across the intestinal epithelium J. Control. Release 21 49 62 10.1016/0168-3659(92)90007-E 1:CAS:528:DyaK3sXhtV2ltL8%3D
20. U. I. Schwarz T. Gramatté J. Krappweis R. Oertel W. Kirch 2000 P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans Int. J. Clin. Pharmacol. Ther. 38 161 167 10783825 1:CAS:528:DC%2BD38XovV2isQ%3D%3D (Pubitemid 30193611)
21. J. Shaikh D. D. Ankola V. Beniwal D. Singh M. N. Kumar 2009 Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Eur. J. Pharm. Sci. 37 223 230 19491009 10.1016/j.ejps.2009.02.019 1:CAS:528: DC%2BD1MXms1Oksrg%3D
22. Q. Shen Y. Lin T. Handa M. Doi M. Sugie K. Wakayama N. Okada T. Fujita A. Yamamoto 2006 Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies Int. J. Pharm. 313 49 56 16500056 10.1016/j.ijpharm.2006.01.020 1:CAS:528:DC%2BD28XjtVGqurg%3D
23. Q. Shen W. Li Y. Lin H. Katsumi N. Okada T. Sakane T. Fujita A. Yamamoto 2008 Modulating effect of polyethylene glycol on the intestinal transport and ab sorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies J. Pharm. Pharmacol. 60 1633 1641 19000368 10.1211/jpp.60.12.0009 1:CAS:528:DC%2BD1cXhsVyqu7zF
24. Y. Shono H. Nishihara Y. Matsuda S. Furukawa N. Okada T. Fujita A. Yamamoto 2004 Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes J. Pharm. Sci. 93 877 885 14999725 10.1002/jps.20017 1:CAS:528:DC%2BD2cXivF2lsbo%3D (Pubitemid 38420399)
25. S. C. Sutton M. T. S. Rinaldi J. M. McCarthy K. E. Vukovinsky 2002 A statistical method for the determination of absorption rate constant estimated using the rat single pass intestinal perfusion model and multiple linear regression J. Pharm. Sci. 91 1046 1053 11948543 10.1002/jps.10081 1:CAS:528:DC%2BD38XjtFKhurY%3D (Pubitemid 34640929)
26. M. Thanou S. Henderson A. Kydonieus C. Elson 2007 Nsulfonato-N,O- carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules J. Control. Release 117 171 178 17184870 10.1016/j.jconrel.2006.11.002 1:CAS:528:DC%2BD2sXht1CmsL4%3D (Pubitemid 46161881)
27. T. Uchiyama A. Yamamoto H. Hatano T. Fujita S. Muranishi 1996 Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane Biol. Pharm. Bull. 19 1618 1621 8996651 1:CAS:528:DyaK2sXisValug%3D%3D (Pubitemid 27044957)
28. J. Wang D. Chow H. Heiati W. C. Shen 2003 Reversible lipidization for the oral delivery of salmon calcitonin J. Control. Release 88 369 380 12644363 10.1016/S0168-3659(03)00008-7 1:CAS:528:DC%2BD3sXitVGhsLo%3D (Pubitemid 36331879)
29. Y. Wang D. Hao W. D. Stein L. Yang 2006 A kinetic study of Rhodamine123 pumping by P-glycoprotein Biochim. Biophys. Acta 1758 1671 1676 16854369 10.1016/j.bbamem.2006.06.004 1:CAS:528:DC%2BD28XhtVGis7zI (Pubitemid 44466701)
30. K. W. Ward L. M. Azzarano 2004 Preclinical pharmacokinetic properties of the P-glycoprotein inhibitor GF120918A (HCl salt of GF120918,9,10-dihydro-5- methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl) ethyl]phenyl]-4-acridine-carboxamide) in the mouse, rat, dog, and monkey J. Pharmacol. Exp. Ther. 310 703 709 15056727 10.1124/jpet.104.068288 1:CAS:528:DC%2BD2cXmtVyktr4%3D (Pubitemid 38988916)
31. S. R. Wu G. Chen L. Wang M. J. Zhou F. D. Cui 2003 effects of borneol on the pharmacokinetics and biopharmaceutics of rifampicin Journal of Shenyang Pharmaceutical University 20 245 248 1:CAS:528:DC%2BD2cXktFymtbg%3D
32. A. Yamamoto T. Uchiyama R. Nishikawa T. Fujita S. Muranishi 1996 Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane J. Pharm. Pharmacol. 48 1285 1289 9004192 10.1111/j.2042-7158.1996. tb03937.x 1:CAS:528:DyaK2sXnsFOnug%3D%3D
33. S. Yamashita T. Furubayashi M. Kataoka T. Sakane H. Sezaki H. Tokuda 2000 Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells Eur. J. Pharm. Sci. 10 195 204 10767597 10.1016/S0928-0987(00) 00076-2 1:CAS:528:DC%2BD3cXitlOksL8%3D (Pubitemid 30190095)
34. L. Zhang Y. Zheng M. S. S. Chow Z. Zuo 2004 Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model Int. J. Pharm. 287 1 12 15541906 10.1016/j.ijpharm.2004.08.020 1:CAS:528: DC%2BD2cXps1Oqt7g%3D (Pubitemid 39487237)